Skip to main content
. Author manuscript; available in PMC: 2013 Mar 6.
Published in final edited form as: J Alzheimers Dis. 2010;19(3):1081–1091. doi: 10.3233/JAD-2010-1303

Table 3.

LMW serum proteins with a different spectral count in three same subject samples before versus after cognitive decline. Qualifications: 1. Proteins were identified by at least four spectra within a single disease group, 2. Proteins demonstrated ≥ 100% difference in spectral count between before and after cognitive decline, 3. The direction of change in spectral count was the same in at least two subjects and could not be counter directional in the third subject. Percent difference was calculated as difference between before and after cognitive decline samples divided by average of before and after cognitive decline samples. Proteins in bold were exclusively found either before or after cognitive decline

Regulation Accession Protein name Spectra
% difference after/before cognitive decline
before Sample A cognitive Sample B decline Sample C after Sample A cognitive Sample B decline Sample C
P78547 Prosaposin 0 0 0 1 2 1 200%
P08493 Matrix gla protein 0 0 0 3 0 1 200%
Q32LZ2 Biliverdin reductase B 0 0 0 1 0 3 200%
Q86UQ9 Citron 0 0 0 2 2 0 200%
095740 Serine (or cysteine) proteinase inhibitor, clade B, member 4 0 0 0 1 0 3 200%
Q6EZF6 Predicted: similar to neutrophil defensin 1 precursor 0 2 1 0 4 18 152%
P31151 S100 calcium-binding protein A7 0 1 0 1 1 4 143%
Q59EA4 Phospholipase D1, phophatidylcholine-specific 0 0 1 2 1 2 133%
Q16782 Serum amyloid A2 0 0 1 1 1 2 120%
O00109 Keratin 9 6 1 7 0 0 0 200%
Q9P190 Inter-alpha (globulin) inhibitor H4 2 4 4 0 0 0 200%
Q02985 Complement factor h isoform a precursor 4 2 4 1 0 0 164%
Q2KHQ6 Apolipoprotein 11 isoform a precursor 3 3 1 0 1 0 150%
Q6GSJ0 Keratin 1 36 5 7 3 4 3 131%
043608 Roundabout, axon guidance receptor, homolog 2 2 2 0 0 1 0 120%
Q9UGQ0 Rsb-66 protein 2 0 2 0 0 1 120%
Q5SRP4 Apolipoprotein m 4 4 2 2 1 0 108%
Q7L5M9 Keratin 10 8 7 11 2 3 3 106%